|
Z.K. Gadzhieva, K.R. Khamidullin, A.M. Pushkarev
Urinary disturbances in patients with diabetes
|
№6 / 2019
|
|
B.A. Berdichevsky, V.B. Berdichevsky
Detrusor ischemia. Сlinical effects
|
№5 / 2019
|
|
Z.K. Gadzhieva, E.A. Atamanova
Rationale of efficiency and safety of using beta3-adrenergic receptor agonist for treatment of overactive bladder
|
№4 / 2019
|
|
A.V. Kuz’menko, V.V. Kuz’menko, T.A. Gyaurgiev
The efficacy of fesoterodine in patients after transurethral resection of the prostate
|
№1 / 2019
|
|
Yu.A. Kupriyanov, G.R. Kasyan, D.Yu. Pushkar
A role of fesoterodine in treatment of overactive bladder
|
№6 / 2018
|
|
S.H. Al-Shukri, D.Yu. Pushkar, O.I. Apolikhin, M.S. Evdokimov, M.I. Kogan, G.G. Krivoborodov, O.F. Kagan, S.B. Petrov, A.N. Poltoratskyi, I.V. Kuzmin, G.G. Sharvadze
Imidafenacin for treatment of overactive bladder and urgent urinary incontinence: the results of open-label multicenter randomized controlled clinical trial
|
№6 / 2018
|
|
G.R. Kasyan, S.O. Sukhikh, D.Yu. Pushkar
The place of mirabegron in clinical practice
|
№6 / 2017
|
|
Yu.B. Kazilov, Z.K. Gadzhieva
Prevalence of various voiding disorders
|
№5 / 2016
|
|
G.Yu. Yarin, O.V. Shelyakina, V.N. Fedorenko, A.V. Alekseeva, I.A. Vil’gel’mi
Using autonomous electrostimulation device «Erektron» in treating female overactive bladder
|
№5 / 2016
|
|
Z.K. Gadzhieva, Yu.B. Kazilov, Yu.G. Alyaev, I.A. Aboyan
Features of diagnosis and treatment of various disorders of urination by physicians of the Republic of Dagestan and other regions of the North Caucasus and Southern Federal districts
|
№4 / 2016
|
|
G.G. Krivoborodov, E.I. Tur, N.S. Efremov, M.E. Shkolnikov
High doses of trospium chloride in patients with idiopathic overactive bladder. Data of large-scale, multicenter observational program “Resource”
|
№4 / 2016
|
|
G.G. Krivoborodov, E.I. Tur
Validation of urgency scale to detect and assess urgency in patients with overactive bladder
|
№2 (supplement) / 2016
|
Русский
